Pain News and Research

Latest Pain News and Research

Medtronic Resolute DES found effective through two years

According to new clinical data presented today at ACC.12 -- the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) -- the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.

From Medtronic 27 Mar 2012

Pregnancy raises risk of heart attacks

According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.

26 Mar 2012

CSL Behring commences enrollment in SCIg PATH trial for CIDP

CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

26 Mar 2012

Minimally invasive treatments could target ‘hunger hormone’

A minimally invasive treatment may target hunger at its source, another uses X-ray visible embolic beads to block arteries to the stomach and suppress hunger and a third explores the use of stem cells to repair vertebral disc degeneration. Initial results from all these studies were reported at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif.

26 Mar 2012

FDA approves Teva's QNASL nasal aerosol corticosteroid

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.

26 Mar 2012

CCTA identifies more patients with coronary artery disease

Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.

26 Mar 2012

Percutaneous cryoablation freezes and destroys breast cancer tumors

Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation.

26 Mar 2012

Well-balanced diet and exercise can prevent colorectal cancer

When Dessa Ledet repeatedly experienced pain on the right of her body, she never dreamed she would hear the words "you have cancer" when she woke up from a colonoscopy. In fact, she didn't believe that almost three years after her diagnosis she would run in MD Anderson's seventh annual Sprint for Colorectal Oncology Prevention and Education (SCOPE) Run on Saturday, March 24.

26 Mar 2012

Rifaximin and lubiprostone offer best options for patients with IBS

Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans.

26 Mar 2012

Minimally invasive endovascular treatment for CCSVI is safe in patients with MS

Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.

26 Mar 2012

Endovascular aneurysm repair associated with lower mortality rates

A burst aneurysm in the abdominal aorta-the largest blood vessel in the body- is a deadly condition. In fact, about half of these patients don't make it to the hospital in time. Those who do more often than not face open surgery to repair the blood vessel. This study finds that a minimally invasive interventional radiology treatment for ruptured aneurysms called endovascular aneurysm repair is safer than open surgical repair and is associated with lower mortality rates, say researchers Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif.

26 Mar 2012

Nordion introduces new custom dose feature in Canada, Europe for TheraSphere

Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.

26 Mar 2012

Angioplasty safe for MS patients with venous abnormalities

Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and chest is safe—and may be an effective way to treat the venous abnormalities found in those with multiple sclerosis and provide symptom relief.

26 Mar 2012

New embolization procedure may bring hope to men with enlarged prostate

A new interventional radiology treatment, prostatic artery embolization, may bring hope to men with debilitating symptoms caused by an enlarged prostate, say the group of researchers who pioneered its use.

26 Mar 2012

Medtronic announces results from two Symplicity system trials on treatment-resistant hypertension

Medtronic, Inc., announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment-resistant hypertension, according to data from two clinical trials presented at the 2012 American College of Cardiology (ACC) meeting.

From Medtronic 26 Mar 2012

New guidelines for CT-guided biopsies of lung nodules reduce radiation exposure

New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths.

26 Mar 2012

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

For the first time NHS patients in Wales with peripheral nerve pain (known as peripheral neuropathic pain) can be treated with a patch containing capsaicin, which can provide at least 12 weeks pain relief following a single 30- or 60-minute application.

25 Mar 2012

Ibuprofen may be used effectively for altitude sickness: Study

Altitude sickness manifests by symptoms including a headache, fatigue, dizziness and sometimes nausea and vomiting. In addition, patients most likely also feel like they are working harder to breathe, like they are constantly trying to catch their breath. It normally takes days to weeks to fully acclimate to a higher altitude. It affects between 25 percent and 40 percent of the population and can be debilitating.

25 Mar 2012

Lawmakers examine how Medicare, Medicaid can help stop prescription painkiller abuse

Lawmakers held a hearing Thursday on what steps the federal government can take to help prevent the abuse of prescription painkillers.

23 Mar 2012

Aternative pain medication without narcotics safe after sinus surgery

Patients who have undergone sinus surgery can safely take an alternative pain medication that does not cause the side effects of narcotics such as fentanyl and Vicodin, a Loyola University Health System study has found.

23 Mar 2012